Online: Bloomberg UTV

Troikaa Pharma to get US patent

Published on Mon, Feb 8, 2010 at 10:46 IST

AHMEDABAD: Troikaa Pharmaceuticals, a Gujarat based fast growing healthcare company, is likely to get US patent for its novel drug delivery form of Diclofenac injections-Dyanapar AQ.

"Troikaa is shortly to get US patent for its Dyanapar AQ 1 ml injections, as proceedings at the USFDA have got over, we are just awaiting certificate and confirmation from them(USFDA)," Managing Director Troikaa Pharmaceuticals Ketan Patel told PTI.

Diclofenac injections are used for management of painful inflammatory conditions, and-Dyanapar AQ-is the world's first painkiller injection that can be administered on a patient's shoulder. There is reportedly a huge market for these injections which the company is expected to tap.

"Proceeding for patent in Israel for this injection is also almost over and it would be received soon," he said.

"Last month we had got the Eurasian patent for this injection, that will enable us to cover almost all CIS countries including Russia," he added.

The company sought global protection for its novel product by filing a PCT (Patent Cooperation Treaty) application with the World Intellectual Property Organisation.

Subsequently, it filed for global patents in several countries, which included regulated as well as non-regulated countries, company portal stated.

http://www.bloombergutv.com